Original Articles: Asthma, Lower Airway Diseases
Perception of airflow obstruction in patients hospitalized for acute asthma

https://doi.org/10.1016/S1081-1206(10)60117-2Get rights and content

Background

Little is known about the perception of airflow obstruction in patients hospitalized for acute asthma.

Objectives

To evaluate patient perception of airflow obstruction at hospital discharge and at a 2-week follow-up visit and to determine whether symptom control and/or severity of airflow obstruction identified patients at risk for acute asthma after discharge.

Methods

In a prospective cohort study of inner-city adults hospitalized for acute asthma from April 1, 2001, through October 31, 2002, symptom control (Asthma Control Questionnaire) and airflow obstruction (forced expiratory volume in 1 second [FEV1] percentage predicted) were evaluated at discharge and 2 weeks after discharge. We evaluated perception of airflow obstruction (symptom control vs FEV1 percentage predicted) and perception of change in airflow obstruction (change in symptom control vs percentage change in FEV1) between the 2 visits. Acute asthma after discharge was defined as an emergency department visit or hospitalization for asthma within 90 days of discharge.

Results

In fifty-one participants, symptom control was not significantly associated with airflow obstruction at hospital discharge (P = .30), indicating poor perception of airflow obstruction. Among the 41 participants (80.4% of those enrolled) who completed the follow-up visit, change in symptom control was not significantly associated with change in airflow obstruction (P = .20), indicating poor perception of change in airflow obstruction. Greater airflow obstruction at follow-up (P = .02) and a smaller improvement in airflow obstruction (P = .03), but not symptom control, were associated with a higher risk of acute asthma after discharge.

Conclusions

Patients hospitalized for acute asthma have poor perception of airflow obstruction and change in airflow obstruction. Objective measurements of lung function should guide treatment decisions after discharge in this population.

Section snippets

INTRODUCTION

Asthma is a chronic airway disorder characterized by variable airflow obstruction and respiratory symptoms, punctuated by periods of acute deterioration (acute asthma). Severe episodes of acute asthma result in approximately 475,000 hospitalizations per year in the United States.1 Patients with asthma may be unable to appreciate the severity of airflow obstruction (ie, have poor perception of airflow obstruction),2, 3, 4, 5 which may contribute to delays in seeking medical attention,6, 7

METHODS

This was a prospective cohort study of adults (≥18 years old) admitted with an attending physician diagnosis of acute asthma and airflow obstruction on spirometry to 1 of 2 inner-city academic medical centers from April 1, 2001, through October 31, 2002. Participants were excluded if they had a diagnosis of another chronic respiratory disorder, had a contraindication to inhaled corticosteroids or oral corticosteroids, were discharged to locations other than home, were previous participants,

RESULTS

There were 51 participants (78% of eligible patients agreed to participate) in this study (Table 1). Most were African American women who had been diagnosed as having asthma approximately 30 years ago. More than three-quarters had an ED visit, more than half had been hospitalized for asthma within the year before enrollment, and approximately two-thirds had at least 1 episode of near-fatal asthma. The median hospital length of stay was 3 days (interquartile range, 2-5 days). Forty-one (80%) of

DISCUSSION

In this high-risk, inner-city population of adults with asthma, perception of airflow obstruction was poor at both hospital discharge and a 2-week follow-up visit. There was also evidence of poor perception of change in airflow obstruction between the 2 visits. In addition, although asthma symptom control at each visit was not predictive of subsequent episodes of acute asthma within 90 days of discharge, more severe airflow obstruction at the follow-up visit and a smaller improvement in airflow

ACKNOWLEDGMENTS

We thank Jeffery T. Charbeneau, MS, for his assistance with statistical analyses and reviewing early drafts of the manuscript.

REFERENCES (31)

  • GE Hardie et al.

    Understanding how asthmatics perceive symptom distress during a methacholine challenge

    J Asthma

    (2002)
  • Y Kikuchi et al.

    Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma

    N Engl J Med

    (1994)
  • A Chetta et al.

    Personality profiles and breathlessness perception in outpatients with different gradings of asthma

    Am J Respir Crit Care Med

    (1998)
  • TS Kwan-Gett et al.

    One-year experience with an inpatient asthma clinical pathway

    Arch Pediatr Adolesc Med

    (1997)
  • R Lantner et al.

    Inpatient management of asthma in the Chicago suburbs: the Suburban Asthma Management Initiative (SAMI)

    J Asthma

    (2005)
  • Cited by (19)

    • Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD): Measurement Properties of Novel Patient-Reported Symptom Measures

      2022, Journal of Allergy and Clinical Immunology: In Practice
      Citation Excerpt :

      Eradication of or a reduction in the frequency and severity of symptoms is an indicator of asthma control and a goal of asthma management.3,7,8 However, there is a poor correlation between objective measures of disease severity (eg, FEV1 and PEF) and patients’ self-reported experience of asthma symptoms.9-11 Asthma symptom severity can only be evaluated by the patients themselves and, as such, well-developed patient-reported outcome (PRO) measures are necessary for characterizing these experiences in clinical studies.

    • Assessing Asthma Symptoms in Adolescents and Adults: Qualitative Research Supporting Development of the Asthma Daily Symptom Diary

      2016, Value in Health
      Citation Excerpt :

      Among the goals of asthma management (as highlighted in clinical guidelines), and an indicator of overall asthma control, is the eradication of or reduction in asthma symptoms [7–9]. Nevertheless, there is a poor correlation between the aforementioned objective measures of disease severity and patients’ experience of asthma symptoms [10–12]. To provide a holistic understanding of patient disease severity and asthma control in clinical research, there is a need for standardized ways of assessing patients’ experience of asthma symptoms.

    • Asthma outcomes: Symptoms

      2012, Journal of Allergy and Clinical Immunology
      Citation Excerpt :

      In addition, many trials employ “homemade” instruments to assess symptoms (ie, newly derived endpoints, such as asthma-free days, based on alternative analysis of the data collected by the instruments) that have neither been formally validated as an outcome measure nor described in published manuscripts, raising questions about the value of such assessments and precluding comparisons across studies. There is also limited validation of instruments in diverse populations, which is problematic given differences in symptom perception and reporting across different patient subgroups.8-10 Furthermore, evidence of minimal clinically important difference in a change in symptoms in longitudinal studies is largely lacking.

    • Perioperative Respiratory Monitoring in Congenital Heart Disease Patients

      2023, Congenital Heart Disease in Pediatric and Adult Patients: Anesthetic and Perioperative Management, Second Edition
    View all citing articles on Scopus

    Disclosures: Authors have nothing to disclose.

    Funding Sources: Dr Davis was supported at the time of analysis and manuscript preparation and Dr Stein is supported currently by National Institutes of Health Training Grant HL007605. At the time of data collection, Dr Krishnan was supported by National Institutes of Health grant HL67850.

    View full text